DaVita Announcing Opening of Research Facility and Call Center in Metro Denver Area
November 17 2011 - 10:29AM
Business Wire
DaVita Inc. (NYSE: DVA), a leading provider of kidney care
services that is committed to improving the quality of life for
those diagnosed with chronic kidney disease (CKD), today announced
that it has chosen the Denver metropolitan area to locate two
expanding parts of the company’s business. In total, DaVita® will
be bringing as many as 200 quality jobs with benefits to the metro
area. The location of each facility has not yet been announced.
First, DaVita Clinical Research® (DCR®) will be expanding its
capability by building a new early clinical research unit adding
medical, technical and scientific jobs to the community. This
facility will provide the Denver metro area with additional
opportunities to attract the world’s leading health care
innovators, including pharmaceutical, biotech and medical device
companies. This expansion of service shows a clear commitment to
advancing the knowledge and practice of kidney care.
Secondly, DaVita is creating a call center in metro Denver that
will be focused on finding a place for patients to get dialysis,
whether traveling away from home or looking for a new permanent
dialysis center. The center will take calls from patients, family
members, hospitals and doctors and will help patients find a center
while traveling even if there are no DaVita centers in the area
they are visiting. DaVita’s existing call center, located in
Malvern, Penn., makes thousands of these placements (both visiting
and permanent) each month, and is expanding to Denver to handle the
increased call volume.
“We are bringing these jobs to our new headquarters city because
we have found Denver to be a great community to live and work in
and a great community in which to do business,” said DaVita
Chairman and CEO Kent Thiry. “Everything then mayor, now Governor
John Hickenlooper promised regarding quality of life and the
positive business environment in Denver and Colorado has turned out
to be true and exceeded our expectations.”
“DaVita’s latest expansion is welcome news for Colorado,” said
Colorado Governor John Hickenlooper. “DaVita knows that Colorado is
a great state and we aim to make everyone know it is the best state
in the nation for business.”
With these new jobs, DaVita will have an even greater impact on
the local economy. Since DaVita announced the relocation of its
corporate headquarters to Denver, DaVita has added more than 320
new jobs (not including today’s announcement) in metro Denver.
Currently, the company has nearly 1,100 teammates in Colorado.
DaVita also affects the local economy in many ways beyond hiring
new teammates. Each year the company brings 4,000-5,000 teammates
to Denver from all over the country for DaVita’s training and
development programs, representing nearly $2.5 million to the
Denver economy through hotel stays, restaurants and other related
revenue.
DaVita, DaVita Clinical Research and DCR are registered U.S.
trademarks of DaVita Inc. All other trademarks are the property of
their respective owners.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease.
DaVita strives to improve patients’ quality of life by innovating
clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services.
As of Sept. 30, 2011, DaVita operated or provided administrative
services at 1,777 dialysis facilities, serving approximately
138,000 patients. DaVita supports numerous programs dedicated to
creating positive, sustainable change in communities around the
world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu. For more information, please
visit www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024